NASDAQ: JBIO
Jade Biosciences Inc Stock Ownership - Who owns Jade Biosciences?

Insider buying vs selling

Have Jade Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fairmount Funds Management LLCDirector2025-10-061,333,126$9.14
$12.18MBuy

1 of 1

JBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JBIO insiders and whales buy or sell their stock.

JBIO Shareholders

What type of owners hold Jade Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.35%7,085,423$108.69MInstitution
Fairmount Funds Management LLC9.23%4,553,494$69.85MInsider
Fairmount Funds Management LLC9.23%4,553,494$69.85MInstitution
Maha Katabi7.61%3,758,686$57.66MInsider
Sofinnova Venture Partners X LP7.61%3,758,686$57.66MInsider
Ra Capital Management LP7.44%3,671,083$56.31MInstitution
Bellevue Group Ag7.09%3,501,502$53.71MInstitution
Venrock Adviser LLC6.52%3,220,364$49.40MInstitution
Janus Henderson Group PLC6.29%3,105,669$47.64MInstitution
Avidity Partners Management LP5.68%2,801,416$42.97MInstitution

1 of 3

JBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JBIO72.82%27.18%Net Buying
ANRO76.45%18.01%Net Selling
ZVRA69.89%21.79%Net SellingNet Buying
SANA53.53%46.47%Net Selling
IVA27.10%0.00%

Jade Biosciences Stock Ownership FAQ

Who owns Jade Biosciences?

Jade Biosciences (NASDAQ: JBIO) is owned by 103.82% institutional shareholders, 38.76% Jade Biosciences insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Jade Biosciences shareholder, owning 4.55M shares representing 9.23% of the company. Fairmount Funds Management LLC's Jade Biosciences shares are currently valued at $69.85M.

If you're new to stock investing, here's how to buy Jade Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.